Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial

por Wallis, Robert S, Ginindza, Sibuse, Beattie, Trevor, Arjun, Nishanee, Likoti, Morongwe, Edward, Vinodh A, Rassool, Mohammed, Ahmed, Khatija, Fielding, Katherine, Ahidjo, Bintou A, Vangu, Mboyo D T, Churchyard, Gavin
Publicado 2021

Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial

por Wallis, Robert S., Ginindza, Sibuse, Beattie, Trevor, Arjun, Nishanee, Likoti, Morongwe, Sebe, Modulakgotla, Edward, Vinodh A., Rassool, Mohammed, Ahmed, Khatija, Fielding, Katherine, Ahidjo, Bintou A., Vangu, Mboyo D. T., Churchyard, Gavin
Publicado 2022

A blood RNA transcriptome signature for COVID-19

por Kwan, Philip Kam Weng, Cross, Gail B., Naftalin, Claire M., Ahidjo, Bintou A., Mok, Chee Keng, Fanusi, Felic, Permata Sari, Intan, Chia, Siok Ching, Kumar, Shoban Krishna, Alagha, Rawan, Tham, Sai Meng, Archuleta, Sophia, Sessions, October M., Hibberd, Martin L., Paton, Nicholas I.
Publicado 2021